The FDA Label Warning The FDA-approved prescribing information for isotretinoin states directly: "Isotretinoin may cause depression, psychosis, and, rarely, suicidal ideation, suicide attempts, suicide, and aggressive and/or violent behaviors." The full prescribing information is available via FDA accessdata
Clinical studies focus on treatment efficacy, typically in controlled settings where subjects are trained in how to use the devices
CAS: 137525-51-0 Intended Use: BPC-157 is designed for Research Purposes only
This state of chronic inflammation is an underlying factor in many chronic disease states, says Jandes
These insights offer a solid theoretical basis for developing SQOR as a target for disease diagnosis and therapy, and point to future research directions in the field